We are monitoring the impact of COVID-19 on Thyroid Cancer Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2167
Share on
Share on

Global Thyroid Cancer Market Size, Share, Trends & Growth Analysis Report – Segmented By Treatment, End User & Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 2167
Pages: 180

Global Thyroid Cancer Market Size (2020 to 2025)

The global thyroid cancer market size was valued at USD 275 million in 2020 and is forecasted to grow at a CAGR of 25.45% to reach USD 856.5 million by 2025.

Thyroid tumor is treated by surgery and radiotherapy. Chemotherapy has less part to play in the treatment. Essentially doxorubicin is utilized as an off-label drug for treating patients with plastic thyroid cancer; likewise, some other off-name medications, for example, cisplatin and carboplatin, are being used. However, they have brought down response rates. The high development figure for the thyroid growth therapeutics market is essentially credited to a strong pipeline.

The thyroid cancer Market is strong, as 27 molecules are in different stages of development. There are four molecules in Phase III (3) and Pre-registration (1). These drugs most probably get approved in the next seven years. The FDA has granted Zactima, XL184, and, Zybrestat orphan drug status. Once the above molecules get approved, it will intensify the competition in Thyroid Cancer Market, which results in substantial growth in the market. Current competition in the Thyroid cancer market is significantly less. Some effective treatments like Surgery exist, and chemotherapy drugs are also used. Companies such as Doxorubicin, which aims at managing conditions, are prone to get more considerable success in the future.

MARKET DRIVERS:

The increasing number of thyroid cancer patients and the rise in awareness over the availability of different treatment procedures are lavishing the growth of the thyroid cancer market. Also, increasing investments in the healthcare centers by both private and public organizations are fueling the demand of the market.

Growing support from the government by changing schemes and the launch of reimbursement in favor of the ordinary people is to set up growth opportunities for the market. Increasing demand to improve the treatment procedures with quality and the rise in healthcare expenditure are likely to outshine the growth of the thyroid cancer market. The growing geriatric population is also one of the factors fueling the development of the market.

MARKET RESTRAINTS:

However, treatment for thyroid cancer involves high cost, which restrains the market demand slowly. Also, the cost of installing and maintaining the equipment is a bit expensive, which is a factor limiting the demand of the market. The absence of skilled persons in performing surgeries has remained a challenging factor for market developers. Lack of standardization may also hinder the growth of the thyroid cancer market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Treatment, End-User & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc., Baxter International Inc., Abbott laboratories and App pharmaceuticals LLC.

 

This research report on the global thyroid cancer market has been segmented and sub-segmented based on the treatment, end-user, and region.

Thyroid Cancer Market – By Treatment:

  • Surgery
  • Iodine Therapy
  • External Therapy
  • Thyroxine treatment
  • Chemotherapy
  • Drugs

Based on treatment, the Surgery treatment procedure is witnessed in holding the highest shares of the market. Increasing demand for minimally invasive surgeries across the world, which is more effective in curing the disease with less pain comparatively, is boosting up the growth of the thyroid cancer market. The rise in the awareness over different physicians' techniques and increasing training institutes is spurring this market's demand.

Thyroid Cancer Market – By End User:

  • Hospitals
  • Oncology Centres
  • Hospital Pharmacies
  • Retail Pharmacies

Based on end-user, the hospital's segment is leading with the highest shares of the market. Increasing funds from non-government institutes to ensure quality therapeutic procedures is leveling up the growth of the market. Furthermore, increasing disposable income in urban areas is leveraging the growth rate of the market.

Thyroid Cancer Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America was the leader in the global thyroid cancer market in 2019 and predicted the same to be continuing during the forecast period. The adoption of advanced technologies and the launch of innovative techniques in healthcare centers is surging the growth of the market. Increasing capital income in both developed and developing countries is also a common factor gearing up the demand in this region. Europe is positioned second in leading the highest shares of the market. Stringent rules and regulations by the government in approving drugs to promote patients' well-being after surgeries are magnifying the growth of the market. The Asia Pacific is accounted for in the fastest growth rate from recent years and is also expected to have significant growth opportunities in foreseen years. The increasing aging population and again rise in hospitals' scale is broadening the demand of the market. The Middle East and Africa are deemed to have inclined growth rates in the coming years. 

PROMINENT PLAYERS IN THIS MARKET:

Some of the notable companies operating in the global thyroid cancer market analyzed in this report are Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., Jerome Stevens Pharmaceuticals Inc., Baxter International Inc., Abbott laboratories, and App pharmaceuticals LLC.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Surgery     

                                5.1.3 Iodine Theraphy   

                                5.1.4 External radiotherapy        

                                5.1.5 Thyroxine treatment          

                                5.1.6  chemotherapy     

                                5.1.7 Drugs         

                                5.1.8  Y-o-Y Growth Analysis, By Treatment         

                                5.1.9  Market Attractiveness Analysis, By Treatment       

                                5.1.10 Market Share Analysis, By Treatment       

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Oncology centers 

                                5.2.4 Hospital Pharmacies            

                                5.2.5 Retail Pharmacies 

                                5.2.6 Y-o-Y Growth Analysis, By End User             

                                5.2.7 Market Attractiveness Analysis, By End User           

                                5.2.8 Market Share Analysis, By End User             

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By End User

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Baxter International Inc                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Mylan pharmaceuticals Inc                  

                8.3 Alara Pharmaceutical Corporation                    

                8.4  Bristol Myers co                       

                8.5  Abbott laboratories                               

                8.6 Teva parenteral medicines Inc                           

                8.7 App pharmaceuticals llc                         

                8.8  Jerome Stevens Pharmaceuticals Inc                             

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Thyroid Cancer Market, By Region, From 2019-2024 ( USD Million )
  2. Global Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  3. Global Surgery Market, By Region, From 2019-2024 ( USD Million )
  4. Global Iodine Theraphy Market, By Region, From 2019-2024 ( USD Million )
  5. Global External radiotherapy Market, By Region, From 2019-2024 ( USD Million )
  6. Global Thyroxine treatment Market, By Region, From 2019-2024 ( USD Million )
  7. Global chemotherapy Market, By Region, From 2019-2024 ( USD Million )
  8. Global Drugs Market, By Region, From 2019-2024 ( USD Million )
  9. Global Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  10. Global Hospitals Market, By Region, From 2019-2024 ( USD Million )
  11. Global Oncology Centers Market, By Region, From 2019-2024 ( USD Million )
  12. Global Hospital Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  13. Global Retail Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  14. North America Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  15. North America Surgery Market, By Region, From 2019-2024 ( USD Million )
  16. North America Iodine Theraphy Market, By Region, From 2019-2024 ( USD Million )
  17. North America External radiotherapy Market, By Region, From 2019-2024 ( USD Million )
  18. North America Thyroxine treatment Market, By Region, From 2019-2024 ( USD Million )
  19. North America chemotherapy Market, By Region, From 2019-2024 ( USD Million )
  20. North America Drugs Market, By Region, From 2019-2024 ( USD Million )
  21. North America Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  22. North America Hospitals Market, By Region, From 2019-2024 ( USD Million )
  23. North America Oncology Centers Market, By Region, From 2019-2024 ( USD Million )
  24. North America Hospital Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  25. North America Retail Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  26. United States Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  27. United States Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  28. Canada Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  29. Canada Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  30. Europe Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  31. Europe Surgery Market, By Region, From 2019-2024 ( USD Million )
  32. Europe Iodine Theraphy Market, By Region, From 2019-2024 ( USD Million )
  33. Europe External radiotherapy Market, By Region, From 2019-2024 ( USD Million )
  34. Europe Thyroxine treatment Market, By Region, From 2019-2024 ( USD Million )
  35. Europe chemotherapy Market, By Region, From 2019-2024 ( USD Million )
  36. Europe Drugs Market, By Region, From 2019-2024 ( USD Million )
  37. Europe Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  38. Europe Hospitals Market, By Region, From 2019-2024 ( USD Million )
  39. Europe Oncology Centers Market, By Region, From 2019-2024 ( USD Million )
  40. Europe Hospital Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  41. Europe Retail Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  42. U.K. Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  43. U.K. Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  44. Germany Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  45. Germany Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  46. France Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  47. France Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  48. Italy Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  49. Italy Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  50. Spain Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  51. Spain Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  52. Asia-Pacific Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  53. Asia-Pacific Surgery Market, By Region, From 2019-2024 ( USD Million )
  54. Asia-Pacific Iodine Theraphy Market, By Region, From 2019-2024 ( USD Million )
  55. Asia-Pacific External radiotherapy Market, By Region, From 2019-2024 ( USD Million )
  56. Asia-Pacific Thyroxine treatment Market, By Region, From 2019-2024 ( USD Million )
  57. Asia-Pacific chemotherapy Market, By Region, From 2019-2024 ( USD Million )
  58. Asia-Pacific Drugs Market, By Region, From 2019-2024 ( USD Million )
  59. Asia-Pacific Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  60. Asia-Pacific Hospitals Market, By Region, From 2019-2024 ( USD Million )
  61. Asia-Pacific Oncology Centers Market, By Region, From 2019-2024 ( USD Million )
  62. Asia-Pacific Hospital Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  63. Asia-Pacific Retail Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  64. Japan Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  65. Japan Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  66. China Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  67. China Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  68. India Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  69. India Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  70. Australia Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  71. Australia Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  72. South Korea Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  73. South Korea Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  74. Latin America Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  75. Latin America Surgery Market, By Region, From 2019-2024 ( USD Million )
  76. Latin America Iodine Theraphy Market, By Region, From 2019-2024 ( USD Million )
  77. Latin America External radiotherapy Market, By Region, From 2019-2024 ( USD Million )
  78. Latin America Thyroxine treatment Market, By Region, From 2019-2024 ( USD Million )
  79. Latin America chemotherapy Market, By Region, From 2019-2024 ( USD Million )
  80. Latin America Drugs Market, By Region, From 2019-2024 ( USD Million )
  81. Latin America Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  82. Latin America Hospitals Market, By Region, From 2019-2024 ( USD Million )
  83. Latin America Oncology Centers Market, By Region, From 2019-2024 ( USD Million )
  84. Latin America Hospital Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  85. Latin America Retail Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  86. Brazil Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  87. Brazil Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  88. Argentina Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  89. Argentina Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  90. Mexico Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  91. Mexico Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  92. Rest of Latin America Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  93. Rest of Latin America Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  94. Middle East & Africa Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  95. Middle East & Africa Surgery Market, By Region, From 2019-2024 ( USD Million )
  96. Middle East & Africa Iodine Theraphy Market, By Region, From 2019-2024 ( USD Million )
  97. Middle East & Africa External radiotherapy Market, By Region, From 2019-2024 ( USD Million )
  98. Middle East & Africa Thyroxine treatment Market, By Region, From 2019-2024 ( USD Million )
  99. Middle East & Africa chemotherapy Market, By Region, From 2019-2024 ( USD Million )
  100. Middle East & Africa Drugs Market, By Region, From 2019-2024 ( USD Million )
  101. Middle East & Africa Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  102. Middle East & Africa Hospitals Market, By Region, From 2019-2024 ( USD Million )
  103. Middle East & Africa Oncology Centers Market, By Region, From 2019-2024 ( USD Million )
  104. Middle East & Africa Hospital Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  105. Middle East & Africa Retail Pharmacies Market, By Region, From 2019-2024 ( USD Million )
  106. Middle East Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  107. Middle East Thyroid Cancer Market, By End User, From 2019-2024 ( USD Million )
  108. Africa Thyroid Cancer Market, By Treatment, From 2019-2024 ( USD Million )
  109. Africa Thyroid Cancer Market, By End User, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample